Therapeutics Pipeline
| Program: Indication | Development | Pre-IND | Phase 1 | Phase 2 |
|---|---|---|---|---|
| AS1411: Acute Myeloid Leukemia (AML) |  |
|
|
|
| AS1411: Renal Cell (Kidney) | |
|
|
|
| AS1411: Pancreatic | |
|
|
 |
| ALAN: Acute Myeloid Leukemia (AML) | |
|
|
|
| ALAN: Neuroblastoma | |
|
|
|
| ALAN: Pancreatic | |
|
|
|
| ALAN-RE: Radiation Enhancement-Breast (Triple Negative) | |
|
|
|
| ALAN-CE: Contrast Enhancement-Solid Tumors | |
|
|
|
| STARS: All types | |
|
|
|
| RAS-F: Pancreatic | |
|
|
|
| RAS-F: Lung | |
|
|
|
| RAS-F: Colorectal | |
|
|
|